 | • レポートコード：D0GIR-06986 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、バイオスラックス（炭疽菌ワクチン）の世界市場を広く調査・分析し、今後の市場展望をまとめております。バイオスラックス（炭疽菌ワクチン）の種類別市場規模（生ワクチン、無細胞PAワクチン）、用途別市場規模（ヒト用、動物用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merial、Biogénesis-Bago、Bayer Sanidad Animal、Merck、Tiankang、Zoetis、Rosenbusch、PharmAthene、Colorado Serum、CAVAC、Prondil、Botswana Vaccine Institute、Agrovet、Intervac、CDV、IVPM、Vecol、Ceva Santé Animale、Indian Immunologicals、CVCRI、JOVAC ・地域別グローバル市場分析 2015年-2020年 ・バイオスラックス（炭疽菌ワクチン）の北米市場（アメリカ、カナダ、メキシコ） ・バイオスラックス（炭疽菌ワクチン）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・バイオスラックス（炭疽菌ワクチン）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・バイオスラックス（炭疽菌ワクチン）の南米市場（ブラジル、アルゼンチン） ・バイオスラックス（炭疽菌ワクチン）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：生ワクチン、無細胞PAワクチン ・用途別分析：ヒト用、動物用 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Biothrax (Anthrax Vaccine) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Biothrax (Anthrax Vaccine) sales will be xx in 2020 from Biothrax (Anthrax Vaccine) million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Biothrax (Anthrax Vaccine) market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Biothrax (Anthrax Vaccine) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Biothrax (Anthrax Vaccine) and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Biothrax (Anthrax Vaccine) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biothrax (Anthrax Vaccine) market has been segmented into
Live Vaccines
Cell Free PA Vaccines
By Application, Biothrax (Anthrax Vaccine) has been segmented into:
Human Use
Animal Use
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biothrax (Anthrax Vaccine) market presented in the report. This section sheds light on the sales growth of different regional and country-level Biothrax (Anthrax Vaccine) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biothrax (Anthrax Vaccine) market.
The report offers in-depth assessment of the growth and other aspects of the Biothrax (Anthrax Vaccine) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Biothrax (Anthrax Vaccine) Market Share Analysis
Biothrax (Anthrax Vaccine) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biothrax (Anthrax Vaccine) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biothrax (Anthrax Vaccine) sales, revenue and market share for each player covered in this report.
The major players covered in Biothrax (Anthrax Vaccine) are:
Merial
Biogénesis-Bago
Bayer Sanidad Animal
Merck
Tiankang
Zoetis
Rosenbusch
PharmAthene
Colorado Serum
CAVAC
Prondil
Botswana Vaccine Institute
Agrovet
Intervac
CDV
IVPM
Vecol
Ceva Santé Animale
Indian Immunologicals
CVCRI
JOVAC
Among other players domestic and global, Biothrax (Anthrax Vaccine) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biothrax (Anthrax Vaccine) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biothrax (Anthrax Vaccine), with price, sales, revenue and global market share of Biothrax (Anthrax Vaccine) in 2018 and 2019.
Chapter 3, the Biothrax (Anthrax Vaccine) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biothrax (Anthrax Vaccine) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Biothrax (Anthrax Vaccine) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Biothrax (Anthrax Vaccine) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Biothrax (Anthrax Vaccine) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biothrax (Anthrax Vaccine) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Live Vaccines
1.2.3 Cell Free PA Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Biothrax (Anthrax Vaccine) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Human Use
1.3.3 Animal Use
1.4 Overview of Global Biothrax (Anthrax Vaccine) Market
1.4.1 Global Biothrax (Anthrax Vaccine) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Biothrax (Anthrax Vaccine) Industry Impact
1.6.1 COVID-19 Potential Implications for the Biothrax (Anthrax Vaccine)
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Biothrax (Anthrax Vaccine)
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Merial
2.1.1 Merial Details
2.1.2 Merial Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merial SWOT Analysis
2.1.4 Merial Product and Services
2.1.5 Merial Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biogénesis-Bago
2.2.1 Biogénesis-Bago Details
2.2.2 Biogénesis-Bago Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biogénesis-Bago SWOT Analysis
2.2.4 Biogénesis-Bago Product and Services
2.2.5 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer Sanidad Animal
2.3.1 Bayer Sanidad Animal Details
2.3.2 Bayer Sanidad Animal Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer Sanidad Animal SWOT Analysis
2.3.4 Bayer Sanidad Animal Product and Services
2.3.5 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Tiankang
2.5.1 Tiankang Details
2.5.2 Tiankang Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Tiankang SWOT Analysis
2.5.4 Tiankang Product and Services
2.5.5 Tiankang Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Zoetis
2.6.1 Zoetis Details
2.6.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Zoetis SWOT Analysis
2.6.4 Zoetis Product and Services
2.6.5 Zoetis Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Rosenbusch
2.7.1 Rosenbusch Details
2.7.2 Rosenbusch Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Rosenbusch SWOT Analysis
2.7.4 Rosenbusch Product and Services
2.7.5 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 PharmAthene
2.8.1 PharmAthene Details
2.8.2 PharmAthene Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 PharmAthene SWOT Analysis
2.8.4 PharmAthene Product and Services
2.8.5 PharmAthene Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Colorado Serum
2.9.1 Colorado Serum Details
2.9.2 Colorado Serum Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Colorado Serum SWOT Analysis
2.9.4 Colorado Serum Product and Services
2.9.5 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 CAVAC
2.10.1 CAVAC Details
2.10.2 CAVAC Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 CAVAC SWOT Analysis
2.10.4 CAVAC Product and Services
2.10.5 CAVAC Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Prondil
2.11.1 Prondil Details
2.11.2 Prondil Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Prondil SWOT Analysis
2.11.4 Prondil Product and Services
2.11.5 Prondil Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Botswana Vaccine Institute
2.12.1 Botswana Vaccine Institute Details
2.12.2 Botswana Vaccine Institute Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Botswana Vaccine Institute SWOT Analysis
2.12.4 Botswana Vaccine Institute Product and Services
2.12.5 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Agrovet
2.13.1 Agrovet Details
2.13.2 Agrovet Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Agrovet SWOT Analysis
2.13.4 Agrovet Product and Services
2.13.5 Agrovet Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Intervac
2.14.1 Intervac Details
2.14.2 Intervac Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Intervac SWOT Analysis
2.14.4 Intervac Product and Services
2.14.5 Intervac Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 CDV
2.15.1 CDV Details
2.15.2 CDV Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 CDV SWOT Analysis
2.15.4 CDV Product and Services
2.15.5 CDV Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 IVPM
2.16.1 IVPM Details
2.16.2 IVPM Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 IVPM SWOT Analysis
2.16.4 IVPM Product and Services
2.16.5 IVPM Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Vecol
2.17.1 Vecol Details
2.17.2 Vecol Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Vecol SWOT Analysis
2.17.4 Vecol Product and Services
2.17.5 Vecol Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Ceva Santé Animale
2.18.1 Ceva Santé Animale Details
2.18.2 Ceva Santé Animale Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Ceva Santé Animale SWOT Analysis
2.18.4 Ceva Santé Animale Product and Services
2.18.5 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Indian Immunologicals
2.19.1 Indian Immunologicals Details
2.19.2 Indian Immunologicals Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Indian Immunologicals SWOT Analysis
2.19.4 Indian Immunologicals Product and Services
2.19.5 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 CVCRI
2.20.1 CVCRI Details
2.20.2 CVCRI Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 CVCRI SWOT Analysis
2.20.4 CVCRI Product and Services
2.20.5 CVCRI Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 JOVAC
2.21.1 JOVAC Details
2.21.2 JOVAC Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 JOVAC SWOT Analysis
2.21.4 JOVAC Product and Services
2.21.5 JOVAC Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Biothrax (Anthrax Vaccine) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Biothrax (Anthrax Vaccine) Manufacturer Market Share in 2019
3.3.2 Top 6 Biothrax (Anthrax Vaccine) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Biothrax (Anthrax Vaccine) Sales, Revenue and Market Share by Regions
4.1.1 Global Biothrax (Anthrax Vaccine) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Regions (2015-2020)
4.2 North America Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
4.3 Europe Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
4.5 South America Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Biothrax (Anthrax Vaccine) Sales, Revenue and Market Share by Country
5.1.1 North America Biothrax (Anthrax Vaccine) Sales and Market Share by Country (2015-2020)
5.1.2 North America Biothrax (Anthrax Vaccine) Revenue and Market Share by Country (2015-2020)
5.2 United States Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
5.3 Canada Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
5.4 Mexico Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Biothrax (Anthrax Vaccine) Sales, Revenue and Market Share by Country
6.1.1 Europe Biothrax (Anthrax Vaccine) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Biothrax (Anthrax Vaccine) Revenue and Market Share by Country (2015-2020)
6.2 Germany Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
6.3 UK Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
6.4 France Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
6.5 Russia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
6.6 Italy Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Biothrax (Anthrax Vaccine) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Biothrax (Anthrax Vaccine) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Biothrax (Anthrax Vaccine) Revenue and Market Share by Regions (2015-2020)
7.2 China Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
7.3 Japan Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
7.4 Korea Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
7.5 India Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
7.7 Australia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Biothrax (Anthrax Vaccine) Sales, Revenue and Market Share by Country
8.1.1 South America Biothrax (Anthrax Vaccine) Sales and Market Share by Country (2015-2020)
8.1.2 South America Biothrax (Anthrax Vaccine) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
8.3 Argentina Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Biothrax (Anthrax Vaccine) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Biothrax (Anthrax Vaccine) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Biothrax (Anthrax Vaccine) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
9.3 Turkey Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
9.4 Egypt Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
9.5 South Africa Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Biothrax (Anthrax Vaccine) Sales and Market Share by Type (2015-2020)
10.2 Global Biothrax (Anthrax Vaccine) Revenue and Market Share by Type (2015-2020)
10.3 Global Biothrax (Anthrax Vaccine) Price by Type (2015-2020)
11 Global Biothrax (Anthrax Vaccine) Market Segment by Application
11.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2015-2020)
11.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2015-2020)
11.3 Global Biothrax (Anthrax Vaccine) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Biothrax (Anthrax Vaccine) Sales, Revenue and Growth Rate (2021-2025)
12.2 Biothrax (Anthrax Vaccine) Market Forecast by Regions (2021-2025)
12.2.1 North America Biothrax (Anthrax Vaccine) Market Forecast (2021-2025)
12.2.2 Europe Biothrax (Anthrax Vaccine) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Biothrax (Anthrax Vaccine) Market Forecast (2021-2025)
12.2.4 South America Biothrax (Anthrax Vaccine) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Biothrax (Anthrax Vaccine) Market Forecast (2021-2025)
12.3 Biothrax (Anthrax Vaccine) Market Forecast by Type (2021-2025)
12.3.1 Global Biothrax (Anthrax Vaccine) Sales Forecast by Type (2021-2025)
12.3.2 Global Biothrax (Anthrax Vaccine) Market Share Forecast by Type (2021-2025)
12.4 Biothrax (Anthrax Vaccine) Market Forecast by Application (2021-2025)
12.4.1 Global Biothrax (Anthrax Vaccine) Sales Forecast by Application (2021-2025)
12.4.2 Global Biothrax (Anthrax Vaccine) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Biothrax (Anthrax Vaccine) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biothrax (Anthrax Vaccine) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biothrax (Anthrax Vaccine) Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Biothrax (Anthrax Vaccine) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Merial Basic Information, Manufacturing Base and Competitors
Table 9. Merial Biothrax (Anthrax Vaccine) Major Business
Table 10. Merial Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 11. Merial SWOT Analysis
Table 12. Merial Biothrax (Anthrax Vaccine) Product and Services
Table 13. Merial Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Biogénesis-Bago Basic Information, Manufacturing Base and Competitors
Table 15. Biogénesis-Bago Biothrax (Anthrax Vaccine) Major Business
Table 16. Biogénesis-Bago Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 17. Biogénesis-Bago SWOT Analysis
Table 18. Biogénesis-Bago Biothrax (Anthrax Vaccine) Product and Services
Table 19. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Bayer Sanidad Animal Basic Information, Manufacturing Base and Competitors
Table 21. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Major Business
Table 22. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 23. Bayer Sanidad Animal SWOT Analysis
Table 24. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product and Services
Table 25. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Merck Basic Information, Manufacturing Base and Competitors
Table 27. Merck Biothrax (Anthrax Vaccine) Major Business
Table 28. Merck Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 29. Merck SWOT Analysis
Table 30. Merck Biothrax (Anthrax Vaccine) Product and Services
Table 31. Merck Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Tiankang Basic Information, Manufacturing Base and Competitors
Table 33. Tiankang Biothrax (Anthrax Vaccine) Major Business
Table 34. Tiankang Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 35. Tiankang SWOT Analysis
Table 36. Tiankang Biothrax (Anthrax Vaccine) Product and Services
Table 37. Tiankang Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Zoetis Basic Information, Manufacturing Base and Competitors
Table 39. Zoetis Biothrax (Anthrax Vaccine) Major Business
Table 40. Zoetis Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 41. Zoetis SWOT Analysis
Table 42. Zoetis Biothrax (Anthrax Vaccine) Product and Services
Table 43. Zoetis Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Rosenbusch Basic Information, Manufacturing Base and Competitors
Table 45. Rosenbusch Biothrax (Anthrax Vaccine) Major Business
Table 46. Rosenbusch Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 47. Rosenbusch SWOT Analysis
Table 48. Rosenbusch Biothrax (Anthrax Vaccine) Product and Services
Table 49. Rosenbusch Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. PharmAthene Basic Information, Manufacturing Base and Competitors
Table 51. PharmAthene Biothrax (Anthrax Vaccine) Major Business
Table 52. PharmAthene Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 53. PharmAthene SWOT Analysis
Table 54. PharmAthene Biothrax (Anthrax Vaccine) Product and Services
Table 55. PharmAthene Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Colorado Serum Basic Information, Manufacturing Base and Competitors
Table 57. Colorado Serum Biothrax (Anthrax Vaccine) Major Business
Table 58. Colorado Serum Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 59. Colorado Serum SWOT Analysis
Table 60. Colorado Serum Biothrax (Anthrax Vaccine) Product and Services
Table 61. Colorado Serum Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. CAVAC Basic Information, Manufacturing Base and Competitors
Table 63. CAVAC Biothrax (Anthrax Vaccine) Major Business
Table 64. CAVAC Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 65. CAVAC SWOT Analysis
Table 66. CAVAC Biothrax (Anthrax Vaccine) Product and Services
Table 67. CAVAC Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Prondil Basic Information, Manufacturing Base and Competitors
Table 69. Prondil Biothrax (Anthrax Vaccine) Major Business
Table 70. Prondil Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 71. Prondil SWOT Analysis
Table 72. Prondil Biothrax (Anthrax Vaccine) Product and Services
Table 73. Prondil Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Botswana Vaccine Institute Basic Information, Manufacturing Base and Competitors
Table 75. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Major Business
Table 76. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 77. Botswana Vaccine Institute SWOT Analysis
Table 78. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product and Services
Table 79. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Agrovet Basic Information, Manufacturing Base and Competitors
Table 81. Agrovet Biothrax (Anthrax Vaccine) Major Business
Table 82. Agrovet Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 83. Agrovet SWOT Analysis
Table 84. Agrovet Biothrax (Anthrax Vaccine) Product and Services
Table 85. Agrovet Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Intervac Basic Information, Manufacturing Base and Competitors
Table 87. Intervac Biothrax (Anthrax Vaccine) Major Business
Table 88. Intervac Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 89. Intervac SWOT Analysis
Table 90. Intervac Biothrax (Anthrax Vaccine) Product and Services
Table 91. Intervac Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. CDV Basic Information, Manufacturing Base and Competitors
Table 93. CDV Biothrax (Anthrax Vaccine) Major Business
Table 94. CDV Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 95. CDV SWOT Analysis
Table 96. CDV Biothrax (Anthrax Vaccine) Product and Services
Table 97. CDV Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. IVPM Basic Information, Manufacturing Base and Competitors
Table 99. IVPM Biothrax (Anthrax Vaccine) Major Business
Table 100. IVPM Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 101. IVPM SWOT Analysis
Table 102. IVPM Biothrax (Anthrax Vaccine) Product and Services
Table 103. IVPM Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Vecol Basic Information, Manufacturing Base and Competitors
Table 105. Vecol Biothrax (Anthrax Vaccine) Major Business
Table 106. Vecol Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 107. Vecol SWOT Analysis
Table 108. Vecol Biothrax (Anthrax Vaccine) Product and Services
Table 109. Vecol Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 110. Ceva Santé Animale Biothrax (Anthrax Vaccine) Type and Application
Table 111. Ceva Santé Animale Biothrax (Anthrax Vaccine) Major Business
Table 112. Ceva Santé Animale Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 113. Ceva Santé Animale SWOT Analysis
Table 114. Ceva Santé Animale Biothrax (Anthrax Vaccine) Product and Services
Table 115. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 116. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 117. Indian Immunologicals Biothrax (Anthrax Vaccine) Major Business
Table 118. Indian Immunologicals Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 119. Indian Immunologicals SWOT Analysis
Table 120. Indian Immunologicals Biothrax (Anthrax Vaccine) Product and Services
Table 121. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 122. CVCRI Basic Information, Manufacturing Base and Competitors
Table 123. CVCRI Biothrax (Anthrax Vaccine) Major Business
Table 124. CVCRI Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 125. CVCRI SWOT Analysis
Table 126. CVCRI Biothrax (Anthrax Vaccine) Product and Services
Table 127. CVCRI Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 128. JOVAC Basic Information, Manufacturing Base and Competitors
Table 129. JOVAC Biothrax (Anthrax Vaccine) Major Business
Table 130. JOVAC Biothrax (Anthrax Vaccine) Total Revenue (USD Million) (2018-2019)
Table 131. JOVAC SWOT Analysis
Table 132. JOVAC Biothrax (Anthrax Vaccine) Product and Services
Table 133. JOVAC Biothrax (Anthrax Vaccine) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 134. Global Biothrax (Anthrax Vaccine) Sales by Manufacturer (2018-2019) (K Units)
Table 135. Global Biothrax (Anthrax Vaccine) Revenue by Manufacturer (2018-2019) (USD Million)
Table 136. Global Biothrax (Anthrax Vaccine) Sales by Regions (2015-2020) (K Units)
Table 137. Global Biothrax (Anthrax Vaccine) Sales Market Share by Regions (2015-2020)
Table 138. Global Biothrax (Anthrax Vaccine) Revenue by Regions (2015-2020) (USD Million)
Table 139. North America Biothrax (Anthrax Vaccine) Sales by Countries (2015-2020) (K Units)
Table 140. North America Biothrax (Anthrax Vaccine) Sales Market Share by Countries (2015-2020)
Table 141. North America Biothrax (Anthrax Vaccine) Revenue by Countries (2015-2020) (USD Million)
Table 142. North America Biothrax (Anthrax Vaccine) Revenue Market Share by Countries (2015-2020)
Table 143. Europe Biothrax (Anthrax Vaccine) Sales by Countries (2015-2020) (K Units)
Table 144. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Countries (2015-2020)
Table 145. Europe Biothrax (Anthrax Vaccine) Revenue by Countries (2015-2020) (USD Million)
Table 146. Asia-Pacific Biothrax (Anthrax Vaccine) Sales by Regions (2015-2020) (K Units)
Table 147. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Regions (2015-2020)
Table 148. Asia-Pacific Biothrax (Anthrax Vaccine) Revenue by Regions (2015-2020) (USD Million)
Table 149. South America Biothrax (Anthrax Vaccine) Sales by Countries (2015-2020) (K Units)
Table 150. South America Biothrax (Anthrax Vaccine) Sales Market Share by Countries (2015-2020)
Table 151. South America Biothrax (Anthrax Vaccine) Revenue by Countries (2015-2020) (USD Million)
Table 152. South America Biothrax (Anthrax Vaccine) Revenue Market Share by Countries (2015-2020)
Table 153. Middle East & Africa Biothrax (Anthrax Vaccine) Sales by Countries (2015-2020) (K Units)
Table 154. Middle East & Africa Biothrax (Anthrax Vaccine) Sales Market Share by Countries (2015-2020)
Table 155. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue by Countries (2015-2020) (USD Million)
Table 156. Middle East & Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Countries (2015-2020)
Table 157. Global Biothrax (Anthrax Vaccine) Sales by Type (2015-2020) (K Units)
Table 158. Global Biothrax (Anthrax Vaccine) Sales Share by Type (2015-2020)
Table 159. Global Biothrax (Anthrax Vaccine) Revenue by Type (2015-2020) (USD Million)
Table 160. Global Biothrax (Anthrax Vaccine) Revenue Share by Type (2015-2020)
Table 161. Global Biothrax (Anthrax Vaccine) Sales by Application (2015-2020) (K Units)
Table 162. Global Biothrax (Anthrax Vaccine) Sales Share by Application (2015-2020)
Table 163. Global Biothrax (Anthrax Vaccine) Sales Forecast by Regions (2021-2025) (K Units)
Table 164. Global Biothrax (Anthrax Vaccine) Market Share Forecast by Regions (2021-2025)
Table 165. Global Biothrax (Anthrax Vaccine) Sales Forecast by Type (2021-2025) (K Units)
Table 166. Global Biothrax (Anthrax Vaccine) Market Share Forecast by Type (2021-2025)
Table 167. Global Biothrax (Anthrax Vaccine) Sales Forecast by Application (2021-2025)
Table 168. Global Biothrax (Anthrax Vaccine) Market Share Forecast by Application (2021-2025)
Table 169. Direct Channel Pros & Cons
Table 170. Indirect Channel Pros & Cons
Table 171. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Biothrax (Anthrax Vaccine) Picture
Figure 2. Global Sales Market Share of Biothrax (Anthrax Vaccine) by Type in 2019
Figure 3. Live Vaccines Picture
Figure 4. Cell Free PA Vaccines Picture
Figure 5. Biothrax (Anthrax Vaccine) Sales Market Share by Application in 2018
Figure 6. Human Use Picture
Figure 7. Animal Use Picture
Figure 8. Global Biothrax (Anthrax Vaccine) Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Biothrax (Anthrax Vaccine) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturer in 2019
Figure 29. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Biothrax (Anthrax Vaccine) Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Biothrax (Anthrax Vaccine) Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Regions (2015-2020)
Figure 36. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Regions in 2018
Figure 37. North America Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
Figure 38. Europe Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
Figure 40. South America Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020)
Figure 42. North America Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Biothrax (Anthrax Vaccine) Sales Market Share by Countries (2015-2020)
Figure 44. North America Biothrax (Anthrax Vaccine) Sales Market Share by Countries in 2018
Figure 45. North America Biothrax (Anthrax Vaccine) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Biothrax (Anthrax Vaccine) Revenue Market Share by Countries in 2018
Figure 47. United States Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Countries in 2019
Figure 53. Germany Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Biothrax (Anthrax Vaccine) Revenue Market Share by Regions 2019
Figure 61. China Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Biothrax (Anthrax Vaccine) Sales Market Share by Countries in 2019
Figure 68. South America Biothrax (Anthrax Vaccine) Revenue Market Share by Countries in 2019
Figure 69. Brazil Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Biothrax (Anthrax Vaccine) Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Biothrax (Anthrax Vaccine) Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Biothrax (Anthrax Vaccine) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Biothrax (Anthrax Vaccine) Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Biothrax (Anthrax Vaccine) Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Biothrax (Anthrax Vaccine) Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Biothrax (Anthrax Vaccine) Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Biothrax (Anthrax Vaccine) Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
ヒトロタウイルスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Rotavirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.0% in the forecast period of 2020 to 2025 and will expected to reach USD 8763 million by 2025, from USD 6949.3 million in 2019. The Human Rotaviru…- 動物ワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Animal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Animal Vaccine market report p…
- 口蹄疫（FMD）ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Foot and Mouth Disease (FMD) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1280.5 million by 2025, from USD 900.9 million in 2019. The …
- 結核ワクチン治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Tuberculosis Vaccine Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tuberculosis V…
- 出血熱ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Hemorrhagic Fever Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…